Hanta Virus VaccineE9LBTY27snvvn2QQCERpavMYnbtwUchUT27ErzfPpump
Case file · ante-mortem observation
TERMINAL.
Extreme centralization, terminal illiquidity, and natural selection
Grade Score
38/100
Grade D · TERMINAL
Mkt Cap
$2.4K
+3.3% · 24h
Liquidity
$3.8K
Volume 24h
$42.91
Holders
76
Field Report
Hanta Virus Vaccine's Rapid Hemorrhagic Market Collapse
Here we observe the HV26 token in its final moments—a mere 379 hours into existence, already succumbing to the inexorable laws of tokenomics. With 97.6% of its specimen concentrated in the hands of ten apex predators and a liquidity pool smaller than a modest lunch budget, the creature never stood a chance. Like the virus it claimed to combat, this token proves far more lethal to its own holders than any pathogen ever could.
Diagnosis
Liquidity
Critically low
$3.8K pool depth.
Activity
Flatlined
$42.91 volume / 24h.
Holders
Extreme cluster
Top 5 hold 93.8% of supply.
Cause
Likely Cause
Extreme centralization, terminal illiquidity, and natural selection
Patient Note
It promised salvation but delivered only a -3.3% reminder that good intentions and Solana mint authorities make for a poor vaccine against greed.
Holders
Top 1
79.3%
Top 5
93.8%
Top 10
97.8%
014HRv...tv8f79.29%
028sV8...dhep5.38%
03Gnqe...MxcP5.16%
048wDk...1Mk5AUTOPSY2.68%05HQ1a...Z2CY1.27%
06GnBa...tx2o1.23%
078wDk...1Mk5AUTOPSY1.00%08BEqA...H7rM0.88%
09Hu4R...VuJJ0.52%
10D51J...PAEfAUTOPSY0.40%